Life Sciences MVP: Paul Hastings' Joe O'Malley
Helping Sunovion Pharmaceuticals Inc. reverse a noninfringement finding for patents covering its blockbuster sleep aid Lunesta and secure six additional months of exclusivity worth $1 million a day to the company...To view the full article, register now.
Already a subscriber? Click here to view full article